CONTACT URTICARIA

Clinical trials for CONTACT URTICARIA explained in plain language.

Never miss a new study

Get alerted when new CONTACT URTICARIA trials appear

Sign up with your email to follow new studies for CONTACT URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New pill could tame stubborn hives

Disease control Recruiting now

This study tests a new drug called remibrutinib (a tablet) against a placebo in 44 adults with chronic hives (either spontaneous or triggered by things like pressure or cold). The goal is to see if it reduces symptoms like itching and burning, and how it works in the body. Partic…

Matched conditions: CONTACT URTICARIA

Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

CONTACT URTICARIA

Get alerted when new CONTACT URTICARIA trials appear

New pill could tame stubborn hives